Study details
Enrolling now
A Study of PHST001 in Advanced Solid Tumors
Pheast Therapeutics
NCT IDNCT06840886ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
155
Study length
about 6.1 years
Ages
18+
Locations
10 sites in CA, CT, IL +5
What this study is about
This trial is testing a treatment called PHST001 for people with advanced solid tumors. The goal is to see if the treatment is safe and well-tolerated, and to find the best dose that can be used in future studies.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take PHST001
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Standard assignment
Assignment is predetermined by the study protocol.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: AE, DLT
Secondary: PD, PK